Quantification of nicotine, cotinine, trans-3′-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass-spectrometry procedure for a clinical study on smoking cessation

被引:39
作者
Dobrinas, Maria [1 ]
Choong, Eva [1 ]
Noetzli, Muriel [1 ]
Cornuz, Jacques [2 ]
Ansermot, Nicolas [1 ]
Eap, Chin B. [1 ,3 ]
机构
[1] Univ Lausanne, Hosp Cery, CHUV,Unit Pharmacogenet & Clin Psychopharmacol, Ctr Psychiat Neurosci,Dept Psychiat, CH-1008 Prilly, Lausanne, Switzerland
[2] Univ Lausanne, Dept Ambulatory Care & Community Med, CH-1011 Lausanne, Switzerland
[3] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva 4, Switzerland
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2011年 / 879卷 / 30期
关键词
UPLC-MS/MS; HILIC; Nicotine; Nicotine metabolites; Varenicline; RECEPTOR PARTIAL AGONIST; SOLID-PHASE EXTRACTION; LC-MS-MS; HYDROPHILIC INTERACTION CHROMATOGRAPHY; PERFORMANCE LIQUID-CHROMATOGRAPHY; DOSE PHARMACOKINETICS; HEALTHY SMOKERS; SILICA COLUMNS; IN-VITRO; ESI-MS;
D O I
10.1016/j.jchromb.2011.09.046
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive and specific ultra performance liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of nicotine, its metabolites cotinine and trans-3'-hydroxycotinine and varenicline in human plasma was developed and validated. Sample preparation was realized by solid phase extraction of the target compounds and of the internal standards (nicotine-d4, cotinine-d3, trans-3'-hydroxycotinine-d3 and CP-533,633, a structural analog of varenicline) from 0.5 mL of plasma, using a mixed-mode cation exchange support. Chromatographic separations were performed on a hydrophilic interaction liquid chromatography column (HILIC BEH 2.1 x 100 mm, 1.7 mu m). A gradient program was used, with a 10 mM ammonium formate buffer pH 3/acetonitrile mobile phase at a flow of 0.4 mL/min. The compounds were detected on a triple quadrupole mass spectrometer, operated with an electrospray interface in positive ionization mode and quantification was performed using multiple reaction monitoring. Matrix effects were quantitatively evaluated with success, with coefficients of variation inferior to 8%. The procedure was fully validated according to Food and Drug Administration guidelines and to Societe Francaise des Sciences et Techniques Pharmaceutiques. The concentration range was 2-500 ng/mL for nicotine, 1-1000 ng/mL for cotinine, 2-1000 ng/mL for trans-3'-hydroxycotinine and 1-500 ng/mL for varenicline, according to levels usually measured in plasma. Trueness (86.2-113.6%), repeatability (1.9-12.3%) and intermediate precision (4.4-15.9%) were found to be satisfactory, as well as stability in plasma. The procedure was successfully used to quantify nicotine, its metabolites and varenicline in more than 400 plasma samples from participants in a clinical study on smoking cessation. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:3574 / 3582
页数:9
相关论文
共 43 条
[1]  
[Anonymous], 2001, GUID IND BIOAN METH
[2]   Determination of nicotine and cotinine in human serum by means of LC/MS [J].
Baumann, F. ;
Regenthal, R. ;
Burgos-Guerrero, I. L. ;
Hegerl, U. ;
Preiss, R. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2010, 878 (01) :107-111
[3]   Clinical pharmacology of nicotine: Implications for understanding, preventing, and treating tobacco addiction [J].
Benowitz, N. L. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (04) :531-541
[4]   Trans-3′-hydroxycotinine:: Disposition kinetics, effects and plasma levels during cigarette smoking [J].
Benowitz, NL ;
Jacob, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (01) :53-59
[5]  
Bernert JT, 1997, CLIN CHEM, V43, P2281
[6]   A rapid LC-MS-MS method for the determination of nicotine and cotinine in serum and saliva samples from smokers: Validation and comparison with a radioimmunoassay method [J].
Byrd, GD ;
Davis, RA ;
Ogden, MW .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2005, 43 (03) :133-140
[7]   Measurement of cotinine in urine by liquid chromatography tandem mass spectrometry [J].
Chadwick, Carrie Ann ;
Keevil, Brian .
ANNALS OF CLINICAL BIOCHEMISTRY, 2007, 44 :455-462
[8]   Smoking cessation intervention in clinical practice [J].
Cornuz, J .
ONKOLOGIE, 2002, 25 (05) :413-418
[9]   Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity [J].
Dempsey, D ;
Tutka, P ;
Jacob, P ;
Allen, F ;
Schoedel, K ;
Tyndale, RF ;
Benowitz, NL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (01) :64-72
[10]  
*DEP HLTH HUM SERV, 1990, DEP HLTH HUM SERV PU, P469